Method of treating tardive dyskinesia by oral dosage form of a p

Details Method of treating tardive dyskinesia by oral dosage form of a p Method of treating tardive dyskinesia by oral dosage form of a p

1980-06-02

1981-07-14

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

424274, A61K 3140, A61K 31625

Patent

active

042786673

ABSTRACT:
This invention relates to the use of a physostigmine compound in oral dosage form for the relief, cure or remission of tardive dyskinesia in living animal bodies. The physostigmine compounds include physostigmine, the salts of physostigmine and the esters of physostigmine. The oral dosage form may be in the form of tablets, coated or uncoated, capsules, liquids, powders and any other form of oral dosage which can be ingested into the living animal body. Physostigmine is also known as eserine.

REFERENCES:
Chem. Abst., vol. 77, (1972), 109436(h).

Affiliated with

Also associated with

Rating

Method of treating tardive dyskinesia by oral dosage form of a p does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating tardive dyskinesia by oral dosage form of a p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating tardive dyskinesia by oral dosage form of a p will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2164687